March 5, 2018 / 9:38 PM / 6 months ago

BRIEF-Syndax Pharmaceuticals Reports Q4 Loss Per Share $0.80

March 5 (Reuters) - Syndax Pharmaceuticals Inc:

* SYNDAX PHARMACEUTICALS REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS AND PROVIDES CLINICAL AND BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.80

* SYNDAX PHARMACEUTICALS - FOR Q1 AND FY 2018, TOTAL OPERATING EXPENSES ARE EXPECTED TO BE $22 TO $26 MILLION AND $86 TO $96 MILLION, RESPECTIVELY

* Q4 EARNINGS PER SHARE VIEW $-0.78 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below